Drug · DIN 02459779
REPATHA
AUTOMATED MINI-DOSER WITH PREFILLED CARTRIDGE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 24, 2025; first marketed April 4, 2017.
- Drug Identification Number (DIN)
- 02459779
- Company (DIN owner)
- Amgen Canada IncMississauga, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Evolocumab C10AX13
- Class
- Human
- Record last updated
- July 31, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EVOLOCUMAB | 120 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 15, 2016: NOC 18766Supplement to a New Drug Submission (SNDS) · Addition of a new dosage form (amd) and drug product manufacturing site
Other DINs named REPATHA
- DIN 02446057 · Marketed